Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2013

01-10-2013 | Review Article

Kawasaki disease: basic and pathological findings

Authors: Kei Takahashi, Toshiaki Oharaseki, Yuki Yokouchi, Shiro Naoe, Tsutomu Saji

Published in: Clinical and Experimental Nephrology | Issue 5/2013

Login to get access

Abstract

Kawasaki disease (KD) is considered to be a kind of systemic vasculitis syndrome. It most frequently affects infants and young children and primarily invades medium-sized muscular arteries, including the coronary arteries. The etiology of KD is unknown, but epidemiological data suggest involvement of infectious agents, such as bacteria and viruses, in the onset of KD. In addition, host genetics underlie the disease’s pathogenesis. Histologically, coronary arteritis begins 6–8 days after KD onset, and inflammation of all layers of the artery rapidly ensues. The inflammation spreads completely around the artery, resulting in severe damage to structural components. Then, the artery begins to dilate. KD arteritis is characterized by inflammation consisting of marked accumulation of monocytes/macrophages. Aberrant activation of monocytes/macrophages is thought to be involved in the formation of vascular lesions. Inflammatory-cell infiltration persists until about the 25th day of the disease, after which the inflammatory cells gradually decrease in number. Lesions in all arteries are relatively synchronous, as they evolve from acute to chronic injury. If a giant aneurysm remains or vessel recanalization occurs after thrombotic occlusion of an aneurysm, remodeling of the vascular structure, sometimes including even reocclusion, continues even in the remote stage.
Literature
1.
go back to reference Abe J, Kotzin BL, Jujo K, et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA. 1992;89:4066–70.PubMedCrossRef Abe J, Kotzin BL, Jujo K, et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA. 1992;89:4066–70.PubMedCrossRef
2.
go back to reference Abe J, Kotzin BL, Meissner C, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993;177:791–6.PubMedCrossRef Abe J, Kotzin BL, Meissner C, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993;177:791–6.PubMedCrossRef
3.
go back to reference Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child. 1995;72:308–11.PubMedCrossRef Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child. 1995;72:308–11.PubMedCrossRef
4.
go back to reference Rowley AH, Shulman ST, Mask CA, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis. 2000;182:1183–91.PubMedCrossRef Rowley AH, Shulman ST, Mask CA, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis. 2000;182:1183–91.PubMedCrossRef
5.
go back to reference Brown TJ, Crawford SE, Cornwall ML, et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184:940–3.PubMedCrossRef Brown TJ, Crawford SE, Cornwall ML, et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184:940–3.PubMedCrossRef
6.
go back to reference Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol. 2001;166:1334–43.PubMed Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol. 2001;166:1334–43.PubMed
7.
go back to reference Rowley AH, Baker SC, Shulman ST, et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis. 2004;190:856–65.PubMedCrossRef Rowley AH, Baker SC, Shulman ST, et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis. 2004;190:856–65.PubMedCrossRef
8.
go back to reference Rowley AH, Baker SC, Shulman ST, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis. 2005;192:1757–66.PubMedCrossRef Rowley AH, Baker SC, Shulman ST, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis. 2005;192:1757–66.PubMedCrossRef
9.
go back to reference Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE. 2008;3:e1582.PubMedCrossRef Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE. 2008;3:e1582.PubMedCrossRef
10.
go back to reference Landing HL, Larson E. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol. 1987;1:215–29. Landing HL, Larson E. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol. 1987;1:215–29.
11.
go back to reference Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol Jpn. 1991;41:785–97.PubMed Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol Jpn. 1991;41:785–97.PubMed
12.
go back to reference Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthr Rheum. 1994;37:187–92.CrossRef Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthr Rheum. 1994;37:187–92.CrossRef
13.
go back to reference Amano S, Hazawa F, Kubagawa H, et al. General pathology of Kawasaki disease on the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 1980;30:681–94.PubMed Amano S, Hazawa F, Kubagawa H, et al. General pathology of Kawasaki disease on the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 1980;30:681–94.PubMed
14.
go back to reference Masuda H, Naoe S, Tanaka N. A pathological study of coronary artery in Kawasaki disease (MCLS)—with special reference to morphogenesis of aneurysm. J Jpn Coll Angiol. 1981;21:899–912. Masuda H, Naoe S, Tanaka N. A pathological study of coronary artery in Kawasaki disease (MCLS)—with special reference to morphogenesis of aneurysm. J Jpn Coll Angiol. 1981;21:899–912.
15.
go back to reference Takahashi K, Oharaseki T, Yokouchi Y, Yamada H, Shibuya K, Naoe S. A half-century of autopsy results—incidence of pediatric vasculitis syndromes. Especially Kawasaki disease. Circ J. 2012;76:964–70.PubMedCrossRef Takahashi K, Oharaseki T, Yokouchi Y, Yamada H, Shibuya K, Naoe S. A half-century of autopsy results—incidence of pediatric vasculitis syndromes. Especially Kawasaki disease. Circ J. 2012;76:964–70.PubMedCrossRef
16.
go back to reference Takahashi K, Oharaseki T, Naoe S, et al. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47:305–10.PubMedCrossRef Takahashi K, Oharaseki T, Naoe S, et al. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47:305–10.PubMedCrossRef
17.
go back to reference Fujiwara H, Fujiwara T, Kao TC, Ohshio G, Hamashima Y. Pathology of Kawasaki disease in the healed stage; relationship between typical and atypical cases of Kawasaki disease. Acta Pathol Jpn. 1986;36:857–67.PubMed Fujiwara H, Fujiwara T, Kao TC, Ohshio G, Hamashima Y. Pathology of Kawasaki disease in the healed stage; relationship between typical and atypical cases of Kawasaki disease. Acta Pathol Jpn. 1986;36:857–67.PubMed
18.
go back to reference Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS) with special reference to heart and coronary arterial lesions. Acta Pathol Jpn. 1986;36:1513–27.PubMed Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS) with special reference to heart and coronary arterial lesions. Acta Pathol Jpn. 1986;36:1513–27.PubMed
19.
go back to reference Naoe S, Takahashi K. Kawasaki disease with the focus on sequelae. In: Tanabe T, editor. Intractable vasculitis. Sapporo: Syndromes Hokkaido University Press; 1993. p. 93–103. Naoe S, Takahashi K. Kawasaki disease with the focus on sequelae. In: Tanabe T, editor. Intractable vasculitis. Sapporo: Syndromes Hokkaido University Press; 1993. p. 93–103.
20.
go back to reference Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathologic study. J Pediatr. 1982;100:225–31.PubMedCrossRef Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathologic study. J Pediatr. 1982;100:225–31.PubMedCrossRef
21.
go back to reference Naoe S, Takahashi K, Masuda H, Tanaka N. Coronary findings post Kawasaki disease in children who died of other causes. In: Schulman ST, editor. Kawasaki disease. New York: Liss; 1987. p. 341–6. Naoe S, Takahashi K, Masuda H, Tanaka N. Coronary findings post Kawasaki disease in children who died of other causes. In: Schulman ST, editor. Kawasaki disease. New York: Liss; 1987. p. 341–6.
22.
go back to reference Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults, with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22:138–42.PubMedCrossRef Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults, with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22:138–42.PubMedCrossRef
Metadata
Title
Kawasaki disease: basic and pathological findings
Authors
Kei Takahashi
Toshiaki Oharaseki
Yuki Yokouchi
Shiro Naoe
Tsutomu Saji
Publication date
01-10-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0734-z

Other articles of this Issue 5/2013

Clinical and Experimental Nephrology 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine